Online inquiry

IVTScrip™ mRNA-Human Alkaline phosphatase, (Cap 1, N1-Methylpseudo-UTP, 30 nt-poly(A))   (CAT#: GTTS-WK20222MR)

This product GTTS-WK20222MR is a type of mRNA having 30 nt poly(A) tail and modified with Cap 1 & N1-Methylpseudo-UTP. It ecodes the Alkaline phosphatase protein. This product can be used in Pluripotent stem cell-related researches.
Specifications
Product type mRNA
Modified bases N1-Methylpseudo-UTP
5' Cap Cap 1
Species Human
RefSeq NM_031313.3
Applications Gene therapy research
Format Powder
Quantity 100 µg
Purification Chromatography
Target Gene
Gene ID 251
UniProt ID P10696
Download
Download resources about mRNA therapeutics development to boost your research.
CUSTOMER REVIEWS and Q&As

There are currently no Customer reviews or questions for IVTScrip™ mRNA-Human Alkaline phosphatase, (Cap 1, N1-Methylpseudo-UTP, 30 nt-poly(A)) (GTTS-WK20222MR). Click the button above to contact us or submit your feedback about this product.

See other products
CAT Product Name Product Type CDs
GTTS-WK8855MR IVTScrip™ mRNA-Human ACSS2, (Cap 0, 5-Methyl-CTP & Pseudo-UTP, 120 nt-poly(A)) mRNA ACSS2
GTTS-WK18996MR IVTScrip™ mRNA-Human ALDH1A3, (Cap 1, 2-Thio-UTP, 120 nt-poly(A)) mRNA ALDH1A3
GTTS-WK7601MR IVTScrip™ mRNA-Human ACAA1, (Cap 0, N1-Methylpseudo-UTP, 120 nt-poly(A)) mRNA ACAA1
GTTS-WK16622MR IVTScrip™ mRNA-Human Alkaline phosphatase, (Cap 0, N1-Methylpseudo-UTP, 30 nt-poly(A)) mRNA Alkaline phosphatase
GTTS-WK9150MR IVTScrip™ mRNA-Human ACSM1, (Cap 0, Pseudo-UTP, 30 nt-poly(A)) mRNA ACSM1
GTTS-WK21054MR IVTScrip™ mRNA-Human AK9, (Cap 1, 5-Methyl-CTP, 30 nt-poly(A)) mRNA AK9
GTTS-WK20069MR IVTScrip™ mRNA-Human AOC1, (Cap 1, Pseudo-UTP, 30 nt-poly(A)) mRNA AOC1
GTTS-WK12132MR IVTScrip™ mRNA-Human ACO2, (Cap 1, 5-Methyl-CTP, 120 nt-poly(A)) mRNA ACO2
All products and services are For Research Use Only and CANNOT be used in the treatment or diagnosis of disease.
webinar

EABR Nanoparticles as a Platform Technology for Hybrid mRNA Vaccine Development

November 20th, 2024, 2 PM–3 PM EST

REGISTER NOW